NCT04679610View on ClinicalTrials.gov

"In Vitro Activity of Ceftolozane-tazobactam Against Contemporary Nosocomial Gram - Pathogens Isolated in Russia"

CompletedOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

April 1, 2020

Study Completion Date

December 1, 2020

Conditions
Nosocomial Infection
Trial Locations (1)

214019

The Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy, Smolensk

All Listed Sponsors
lead

The Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC)

OTHER

NCT04679610 - "In Vitro Activity of Ceftolozane-tazobactam Against Contemporary Nosocomial Gram - Pathogens Isolated in Russia" | Biotech Hunter | Biotech Hunter